Cargando…

Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin’s lymphoma: a case report

The effect of the ESHAP (etoposide, methylprednisolone, cytarabine, cisplatin) salvage protocol on serum electrolytes has been previously reported by individual observational studies. The most commonly described electrolyte affected by the ESHAP protocol is magnesium. In addition, hypophosphatemia h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elazzazy, Shereen, El-Geed, Hager A, Yafei, Sumaya Al
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666155/ https://www.ncbi.nlm.nih.gov/pubmed/23750103 http://dx.doi.org/10.2147/IMCRJ.S37286

Ejemplares similares

ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002)

Severe hypomagnesaemia with tetany following ESHAP protocol
por: Majumdar, Gautam
Publicado: (2002)

GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
por: Ramzi, Mani, et al.
Publicado: (2015)

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clinical Trial.
por: Sureda-Balari, Anna, et al.
Publicado: (2022)

ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkin's Lymphoma: A Single Center Experience
por: Park, Sang Hyoung, et al.
Publicado: (2006)

Correction: GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
por: Ramzi, Mani, et al.
Publicado: (2015)

Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin’s Lymphoma in Iran
por: Hatam, Nahid, et al.
Publicado: (2015)

Efficacy of ESHAP Regimen in Transplant Ineligible Patients With Relapsed/Refractory T-Cell Lymphoma
por: Norasetthada, Lalita, et al.
Publicado: (2018)

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
por: Ungur, Rodica, et al.
Publicado: (2015)

Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
por: Kim, Do Young, et al.
Publicado: (2022)

Efficacy of ESHAP versus ICE plus dexamethasone (DICE) as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
por: Boonlerd, Pattamaporn, et al.
Publicado: (2023)

Tenofovir and Severe Symptomatic Hypophosphatemia
por: Kichloo, Asim, et al.
Publicado: (2019)

PB2323: R-ESHAP VS R-ICE AS RESCUE TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE-CENTEREXPERIENCE.
por: Pérez-Pinilla, Belén, et al.
Publicado: (2023)

Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma
por: Pedrosa, Cláudia L., et al.
Publicado: (2021)

Intravenous Iron Induced Severe Hypophosphatemia
por: Guo, Rong R, et al.
Publicado: (2021)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
por: Fang, Wendy, et al.
Publicado: (2019)

Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report
por: Elazzazy, Shereen, et al.
Publicado: (2014)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Severe Hypophosphatemia in Alcohol-Induced Acute Pancreatitis: A Case Report
por: Al-Anbagi, Usamah, et al.
Publicado: (2023)

Severe hypophosphatemia in the critically ill: are we replacing enough?
por: Millwood Hargrave, J, et al.
Publicado: (2015)

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Options for first line therapy of Hodgkin lymphoma
por: Longley, Jemma, et al.
Publicado: (2019)

98 Severe Hypophosphatemia After Iron Infusion: A Serious Complication
Publicado: (2021)

Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma
por: Suresh, Pandalanghat, et al.
Publicado: (2014)

Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017)

Hypophosphatemia in cancer patients
por: Adhikari, Shreedhar, et al.
Publicado: (2021)

Primary Pulmonary Hodgkin Lymphoma
por: Tanveer, Shumaila, et al.
Publicado: (2015)

Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia
por: Choi, Han Saem, et al.
Publicado: (2018)

Acute Chest Pain in an Acute Complicated Pancreatitis with Severe Hypophosphatemia
por: Mahdi, Ahmad, et al.
Publicado: (2022)

Severe Hypophosphatemia Occurring After Repeated Exposure to a Parenteral Iron Formulation
por: Haridas, Keerthana, et al.
Publicado: (2022)

Cutaneous granulomatous reaction as the first manifestation of Hodgkin's lymphoma
por: Moreira, Catarina, et al.
Publicado: (2017)

Optimization of the first line treatment in classical Hodgkin's lymphoma
por: Brice, Pauline
Publicado: (2018)

The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma
por: Pieters, Richard S., et al.
Publicado: (2014)

Posaconazole-Vincristine Coadministration Triggers Seizure in a Young Female Adult: A Case Report
por: Hamdy, Dalia A., et al.
Publicado: (2012)

The utilization of simulated patients for teaching and learning in the pharmacy curriculum: exploring pharmacy students’ and recent alumni’s perceptions using mixed-methods approach
por: ElGeed, Hager, et al.
Publicado: (2021)

Several immune escape patterns in non-Hodgkin's lymphomas
por: Laurent, Camille, et al.
Publicado: (2015)

Early postkidney transplantation hypophosphatemia
por: Ghorbani, Maryam, et al.
Publicado: (2020)

Significance of Hypophosphatemia in Patients with Pneumonia
por: Morimoto, Yasuhiro, et al.
Publicado: (2022)

Hypophosphatemia in Patients With Multiple Myeloma
por: Cancarevic, Ivan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6k35cjlh7h1oo9alng38i1foep